Trial Profile
Second-line pemetrexed vs docetaxel in patients with advanced non-small cell lung cancer
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 04 Apr 2013
Price :
$35
*
At a glance
- Drugs Pemetrexed (Primary) ; Docetaxel
- Indications Non-small cell lung cancer
- Focus Registrational; Therapeutic Use
- 05 Nov 2010 New trial record.